| Diana Marie Winsor, LCSW | |
|
1123 Vermont Ave, Alamogordo, NM 88310-6340 | |
| (575) 921-5351 | |
| Not Available |
| Full Name | Diana Marie Winsor |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 7 Years |
| Location | 1123 Vermont Ave, Alamogordo, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609432335 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | C-11009 (New Mexico) | Primary |
| Entity Name | A Bridge To Healing Counseling Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225610694 PECOS PAC ID: 9739588872 Enrollment ID: O20210524000375 |
News Archive
The Pittcon marketing department is pleased to announce the release of its official 2017 conference and exposition planning tool, Pittcon at a Glance, which is available in app version for mobile devices (Pittcon 2017) and optimized as a web version.
Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion for the approval of MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
The COVID-19 pandemic is still spreading around the world and affecting nearly 2.4 million people, with over 164,000 dead so far. With neither vaccine nor proven therapeutic drug being available so far, the need of the hour is for effective treatment. Now, a new study reports the potential usefulness of a combination of hydroxychloroquine and azithromycin as a treatment in mild cases of COVID-19 infection and urges the need for further evaluation and widespread use if its findings are confirmed.
The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, raising important implications for the development of tests to diagnose and monitor treatment for the disease, according to new research published today in the journal PLOS Pathogens.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Diana Marie Winsor, LCSW 1126 La Bajada Dr, Alamogordo, NM 88310-5593 Ph: (575) 921-5351 | Diana Marie Winsor, LCSW 1123 Vermont Ave, Alamogordo, NM 88310-6340 Ph: (575) 921-5351 |
News Archive
The Pittcon marketing department is pleased to announce the release of its official 2017 conference and exposition planning tool, Pittcon at a Glance, which is available in app version for mobile devices (Pittcon 2017) and optimized as a web version.
Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Evaluation Agency (EMEA) has issued a positive opinion for the approval of MICARDIS® (telmisartan) for the reduction of cardiovascular morbidity.
Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.
The COVID-19 pandemic is still spreading around the world and affecting nearly 2.4 million people, with over 164,000 dead so far. With neither vaccine nor proven therapeutic drug being available so far, the need of the hour is for effective treatment. Now, a new study reports the potential usefulness of a combination of hydroxychloroquine and azithromycin as a treatment in mild cases of COVID-19 infection and urges the need for further evaluation and widespread use if its findings are confirmed.
The immune response to the bacterium that causes tuberculosis (TB) varies between patients of different ethnic origin, raising important implications for the development of tests to diagnose and monitor treatment for the disease, according to new research published today in the journal PLOS Pathogens.
› Verified 2 days ago
Ana Rodriguez, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2669 Scenic Dr, Alamogordo, NM 88310 Phone: 615-924-5444 | |
Janice Walker, LMSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 700 1st St Ste 707, Alamogordo, NM 88310 Phone: 575-415-4950 Fax: 575-377-8254 | |
Johnny Martin, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1900 10th St, Alamogordo, NM 88310 Phone: 505-437-7404 Fax: 505-439-2860 | |
Robin Davis, L.I.S.W. Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 12 Wagon Wheel Rd, Alamogordo, NM 88310 Phone: 575-740-4053 | |
Yasmin A Mukhida, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2360 Indian Wells Rd, Alamogordo, NM 88310 Phone: 575-437-7404 | |
Miss Agnes Dawn Rodriguez, PROVISIONAL LISW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2150 Highway 54 S, Alamogordo, NM 88310 Phone: 575-443-8133 Fax: 575-443-8055 | |
Paula S. Rich-greenwood, LISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1900 10th St, Alamogordo, NM 88310 Phone: 575-437-7404 Fax: 575-439-2860 |